CRVO — CervoMed Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1053691 ·
Last close
$1.50
Market Cap
$22.68M
52W High
$10.00
52W Low
$1.27
ADV30
769,275
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -6,104,950 | -5,895,431 | 21,330,143 | 6,059,804 | 3,974,226 |
| Jun 2026 | 0 | — | -6,678,551 | -6,571,656 | 25,992,471 | 22,462,577 | 3,032,174 |
| Mar 2026 | 0 | — | -8,110,524 | -7,964,158 | 15,112,918 | 7,941,751 | 4,497,203 |
| Dec 2025 | 0 | — | -8,331,519 | -8,087,290 | 22,879,018 | 8,235,469 | 4,656,117 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-27,977,672
Investing CF
$23,192,573
Financing CF
$18,926,963
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.18
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-112,233,665
Inventory
—
Receivables
$0
ST Investments
$2,475,595
EBIT TTM
$-31,164,793
Pretax Income TTM
$-30,349,743
Interest Exp TTM
—
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$331,295
EBITDA
—
Free Cash Flow
$-16,289,585
Enterprise Value
$-3,469,055
Total Cash
$24,938,172
Total Debt
$0
Shares Out
15,119,096
Trailing EPS
$-3.21
Book Value
$1.97
ROE
-107.6%
ROA
-60.8%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -28,294,877 | -26,966,367 | 22,879,018 | 4,656,117 | 18,222,901 | -23,449,963 |
| Dec 2024 | 0 | -18,227,131 | -16,290,695 | 43,081,610 | 3,879,282 | 39,202,328 | -16,530,827 |
| Dec 2023 | 0 | -7,812,895 | -2,171,873 | 9,972,521 | 2,595,747 | 7,376,774 | -7,449,847 |
| Dec 2022 | 0 | -3,475,534 | -5,803,047 | 4,157,706 | 37,442,765 | -33,285,059 | -2,572,759 |
TTM Snapshot
Revenues TTM
$331,295
NetIncome TTM
$-30,349,743
OpCashFlow TTM
—
Assets (Latest)
$25,992,471
Forward EPS
$-1.39
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BYSI | BeyondSpring Inc. | $23.02M | $0.56 | — |
| ETST | Earth Science Tech, Inc. | $23.17M | $0.08 | — |
| TXMD | TherapeuticsMD, Inc. | $22.11M | $1.91 | — |
| IXHL | Incannex Healthcare Inc. | $21.83M | $1.74 | — |
| CPHI | CHINA PHARMA HOLDINGS, INC. | $21.51M | $0.50 | — |
News headlines (Yahoo Finance, 1h cache)
CervoMed Presents Interim Data at CTAD 2026 Showing Neflamapimod Reduces Neurodegeneration Biomarker in Nonfluent Variant Primary Progressive Aphasia
2026-11-16 21:02 · Yahoo
CervoMed Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
2026-11-09 12:30 · Yahoo
CervoMed Announces Publication of Two Peer-Reviewed Research Articles Supporting Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies (DLB)
2026-10-29 11:30 · Yahoo
CervoMed Presents Initial Results of Phase 2a Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Showing Positive Effects on a Key Neurodegeneration Biomarker in Late-Brea
2026-10-12 11:30 · Yahoo
CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
2026-09-22 11:30 · Yahoo
CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFT
2026-09-10 11:30 · Yahoo
CervoMed to Participate in September Investor Conferences
2026-09-08 11:30 · Yahoo
CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)
2026-07-14 11:30 · Yahoo
CervoMed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia
2026-07-09 11:30 · Yahoo
CervoMed Showcases Leadership in Advancing the Treatment and Care of Dementia with Lewy Bodies at the Alzheimer's Association International Conference (AAIC) 2026
2026-07-06 11:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.